Education
About Us
Working with TipRanks
Follow Us
PILA PHARMA AB (DE:5KC)
FRANKFURT:5KC
5KC Stock Chart & Stats
€0.20
€0.09(20.09%)
At close: 4:00 PM EST
€0.20
€0.09(20.09%)
Day’s Range― - ―
52-Week Range€0.09 - €0.41
Previous CloseN/A
Volume2.28K
Average Volume (3M)0.00
Market Cap
€4.77M
Enterprise Value€46.14M
Total Cash (Recent Filing)€1.08M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta-0.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding42,084,415
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.33
Price to Book (P/B)18.15
Price to Sales (P/S)123.19
P/FCF Ratio-12.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
5KC FAQ
What was PILA PHARMA AB’s price range in the past 12 months?
PILA PHARMA AB lowest stock price was €0.09 and its highest was €0.41 in the past 12 months.
What is PILA PHARMA AB’s market cap?
PILA PHARMA AB’s market cap is €4.77M.
When is PILA PHARMA AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PILA PHARMA AB’s earnings last quarter?
Currently, no data Available
Is PILA PHARMA AB overvalued?
According to Wall Street analysts PILA PHARMA AB’s price is currently Overvalued.
Does PILA PHARMA AB pay dividends?
PILA PHARMA AB does not currently pay dividends.
What is PILA PHARMA AB’s EPS estimate?
PILA PHARMA AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PILA PHARMA AB have?
PILA PHARMA AB has 42,084,415 shares outstanding.
What happened to PILA PHARMA AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PILA PHARMA AB?
Currently, no hedge funds are holding shares in DE:5KC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PILA PHARMA AB
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Technical Analysis
Biosergen AB
―
Lipigon Pharmaceuticals AB
―
ExpreS2ion Biotech Holding AB
―
NextCell Pharma AB
―
Spago Nanomedical AB
―